Plenvu

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares gained 2 percent Monday morning after the company confirmed the Food and Drug Administration approved its bowel-cleansing preparation product. What Happened Valeant said the FDA granted approval for PLENVU, the company's polyethylene...

Although the action was light on the FDA approval front, biotech stocks took the spotlight in January, thanks to a few multi-billion-dollar deals announced in the space. Celgene Corporation (NASDAQ: CELG) announced a deal to buy Juno Therapeutics Inc (NASDAQ: JUNO). Ahead of that deal,...